Analysis of four neuroligin genes as candidates for autism

• DOI: 10.1038/sj.ejhg.5201474
• Publication Date: 2005-08-04T01:57:43Z
• Authors: Tero Ylisaukko-oja; Karola Rehnström; Mari Auranen; Raija Vanhala; Reija Alen; Elli Kempas; Pekka Ellonen; Joni A Turunen; Ismo Makkonen; Raili Riikonen; Taina Nieminen-vo...; Lennart von Wendt; Leena Peltonen; Irma Järvelä
• Keywords: Genetic Markers; 0301 basic medicine; Cell Adhesion Molecules, Neuronal; DNA Mutational Analysis; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; 03 medical and health sciences; Synapses; Humans; Autistic Disorder; Carrier Proteins; Microsatellite Repeats; Signal Transduction

Neuroligins are cell-adhesion molecules located at the postsynaptic side of the synapse. Neuroligins interact with beta-neurexins and this interaction is involved in the formation of functional synapses. Mutations in two X-linked neuroligin genes, NLGN3 and NLGN4, have recently been implicated in pathogenesis of autism. The neuroligin gene family consists of five members (NLGN1 at 3q26, NLGN2 at 17p13, NLGN3 at Xq13, NLGN4 at Xp22, and NLGN4Y at Yq11), of which NLGN1 and NLGN3 are located within the best loci observed in our previous genome-wide scan for autism in the Finnish sample. Here, we report a detailed molecular genetic analysis of NLGN1, NLGN3, NLGN4, and NLNG4Y in the Finnish autism sample. Mutation analysis of 30 probands selected from families producing linkage evidence for Xq13 and/or 3q26 loci revealed several polymorphisms, but none of these seemed to be functional. Family-based association analysis in 100 families with autism spectrum disorders yielded only modest associations at NLGN1 (rs1488545, P=0.002), NLGN3 (DXS7132, P=0.014), and NLGN4 (DXS996, P=0.031). We conclude that neuroligin mutations most probably represent rare causes of autism and that it is unlikely that the allelic variants in these genes would be major risk factors for autism.